BMSSC
AZN icon

B. Metzler seel. Sohn & Co’s AstraZeneca AZN Stock Holding History

B. Metzler seel. Sohn & Co’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-4,077
Closed -$636K – 758
2024
Q2 		$636K Sell
4,077
-1,432
-26% -$215K 0.01% 608
2024
Q1 		$746K Sell
5,509
-3,111
-36% -$412K 0.01% 566
2023
Q4 		$1.16M Sell
8,620
-581
-6% -$75.5K 0.01% 473
2023
Q3 		$1.25M Sell
9,201
-1,773
-16% -$242K 0.02% 419
2023
Q2 		$1.57M Sell
10,974
-1,899
-15% -$279K 0.02% 409
2023
Q1 		$1.79M Sell
12,873
-822
-6% -$111K 0.03% 334
2022
Q4 		$1.86M Sell
13,695
-824
-6% -$103K 0.03% 314
2022
Q3 		$1.59M Buy
14,519
+195
+1% +$24.7K 0.03% 332
2022
Q2 		$1.89M Sell
14,324
-1,157
-7% -$152K 0.03% 316
2022
Q1 		$2.05M Sell
15,481
-2,275
-13% -$273K 0.03% 333
2021
Q4 		$2.08M Sell
17,756
-573
-3% -$67.4K 0.03% 317
2021
Q3 		$2.2M Hold
18,329
– – 0.03% 293
2021
Q2 		$2.2M Sell
18,329
-1,650
-8% -$181K 0.03% 283
2021
Q1 		$1.99M Hold
19,979
– – 0.03% 291
2020
Q4 		$2M Buy
+19,979
New +$2.12M 0.04% 271

Other funds holding AZN

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Sanders Capital
Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

B. Metzler seel. Sohn & Co's AZN Position: Q3 2024 in Review

B. Metzler seel. Sohn & Co sold out of AstraZeneca (AZN) in Q3 2024, closing a stake of 4,077 shares — an estimated $636K sold.

B. Metzler seel. Sohn & Co first reported a position in AZN in Q4 2020 and held it in 15 quarters. The position peaked at $2.2M in Q3 2021. 1,230 funds tracked by Wall St. Rank hold AZN as of Q3 2024.

  • B. Metzler seel. Sohn & Co reported no remaining AstraZeneca position as of Q3 2024 after selling out during the quarter.
  • B. Metzler seel. Sohn & Co sold 4,077 AstraZeneca shares in Q3 2024, an estimated $636K.
  • B. Metzler seel. Sohn & Co first reported a position in AstraZeneca in Q4 2020 and held it in 15 quarters.
  • B. Metzler seel. Sohn & Co's AstraZeneca position peaked at $2.2M in Q3 2021.
  • 1,230 funds tracked by Wall St. Rank held AstraZeneca as of Q3 2024.

Based on B. Metzler seel. Sohn & Co's 13F filing for Q3 2024, filed 8 Nov 2024.